Mirae Asset Global Investments’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
PCM
SAM
QPW
Mirae Asset Global Investments's EWTX Position: Q2 2026 in Review
Mirae Asset Global Investments reduced its Edgewise Therapeutics (EWTX) stake by 14% in Q2 2026, selling an estimated $27K and leaving 4,812 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #1122.
Mirae Asset Global Investments first reported a position in EWTX in Q2 2022 and has held it in 17 quarters since. The position peaked at $228K in Q4 2023. 65 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.
- Mirae Asset Global Investments held 4,812 shares of Edgewise Therapeutics worth $196K as of Q2 2026.
- Mirae Asset Global Investments sold 783 Edgewise Therapeutics shares in Q2 2026, an estimated $27K.
- Edgewise Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1122 holding.
- Mirae Asset Global Investments first reported a position in Edgewise Therapeutics in Q2 2022 and has held it in 17 quarters since.
- Mirae Asset Global Investments's Edgewise Therapeutics position peaked at $228K in Q4 2023.
- 65 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.